This pseudogene has no previous evidence of its relation to cancer in the literature, but is related to TMSB4X, which is associated with tumor progression, and metastasis, and was proposed as an NSCLC prognostic biomarker by Yang et al. The gene discussed is TMSB4X; the disease is cancer.